Completed PHASE4 NCT00002146
Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study
Sponsor: Astra USA
Conditions
Cytomegalovirus Infections HIV Infections Hypocalcemia
Interventions
Foscarnet sodium Magnesium sulfate
Updated 5 times since 2017 Last updated: Jun 23, 2005
A PHASE4 clinical study on Cytomegalovirus Infections and HIV Infections, this trial is completed. The trial is conducted by Astra USA and has accumulated 5 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Astra USA
Data source: NIH AIDS Clinical Trials Information Service
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Oklahoma City, United States